Introducing Lasso: A New Food Tech Company Redefining Consumer Packaged Foods
14.10.2025 19:34:00 CEST | Business Wire | Press Release
Lasso today announced its official launch and the introduction of its proprietary technology, Lasso SpinTech. This breakthrough system upends the outdated standards of ultra-processed foods using physics to weave together protein and fiber to make previously unattainable new consumer products. With a new $6.5M raise, Lasso is bringing its technology to the world by launching its own brands and licensing to global partners to create a new generation of healthier foods.
Guided by CEO Mike Messersmith, the Lasso team spent the past year deploying its commercial-scale technology to create innovative clean-label products including protein-packed snacks and pet food—expanding beyond its first plant-based meat application under the Tender Food brand. Lasso’s latest $6.5M in capital, led by Rhapsody Venture Partners with participation from Safar Partners, Claridge Venture Partners, and others, will enable the company to commercialize its transformative technology across new high growth food categories.
“Consumers are no longer accepting the status quo in packaged food. Evidence of that is everywhere from the MAHA movement to vocal pushbacks on ultra-processed foods, and the influence of GLP-1 therapies on consumption patterns and preferences,” said Messersmith. “The industry is desperate for new, innovative solutions, but has been handicapped by antiquated processing machines invented over 100 years ago–and wholly ill-equipped to meet the needs of consumers in 2025. At Lasso, we want to use our technology to step into that void and create progress. Our patented technology offers new ways of creating protein and fiber-rich foods with clean labels and competitive cost structures that will jumpstart major momentum in growing categories across the grocery store.”
Lasso originated at Harvard University’s Wyss Institute, where founders Kit Parker, Luke MacQueen, Christophe Chantre, and Grant Gonzalez invented and spent seven years refining a novel food-processing technology – an “advanced cotton candy machine” capable of creating delicious, nutritious foods with exceptional texture and cost efficiency from nearly any ingredient. Their work culminated in the 2020 launch of Tender Food, which applied Lasso SpinTech to create category-leading plant-based meat. Tender Food will remain a brand under Lasso’s broader portfolio, soon to be joined by several to-be-announced new brands, all built on Lasso SpinTech.
Lasso SpinTech has come a long way since then — scaling from a countertop system in a lab to a commercial-scale system producing hundreds of thousands of pounds of product annually without the need for high heat, excess sugars or artificial additives. Today, the system is compact (about the size of a washing machine) and ultra-efficient (using less energy than a toaster oven) - a fraction of the capital and operating cost of competitive technologies. With nearly limitless ingredient combinations and texture flexibility, Lasso’s technology has the potential to create an endless range of craveable food products.
Messersmith closed: “This fundraise marks a major milestone for Lasso. We are on the cusp of introducing truly innovative new foods made of simple ingredients that everyone understands - both through brands we create and in working with global partners to bring new products to market through licensing agreements. There is nothing on the market that can match what Lasso can achieve with this technology. We are thrilled for people to taste these new products and take this business to a whole new level.”
About Lasso
Lasso is transforming our food system with a breakthrough technology that converts simple ingredients into premium food products. Developed by Harvard scientists at the Wyss Institute, Lasso’s innovative technology “spins” fibers, leveraging centrifugal force to restructure simple ingredients into nutritionally advantaged, affordable food products. With 1,000+ ingredient combinations and vast parameters to control fiber thickness, composition, arrangement, density, and moisture content, Lasso gives food producers the adaptability to navigate shifting supply chains, evolving consumer preferences, and global food trends - setting a new standard for the future of food production. Learn more at www.lassolabs.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251014740080/en/
Contacts
PR Contact
Lindsay Baumann & Jacqui Wimberly
Press@lassolabs.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom